Skip to content
doc.socialdoc.social

Listening

Episode

Morning Brief — Monday, October 5, 2026

Play episode— Morning Brief — Monday, October 5, 2026

Keeps playing through doc social Morning Brief

3 stories this morning, for surgeons and the people who support them.

  • AMA CPT Editorial Panel votes a Category I code for posterior vertebral column arthroplasty, covering Premia Spine's TOPS facet replacement, effective January 1, 2028 — Premia Spine announced Oct 1, 2026 that the AMA CPT Editorial Panel voted to establish a Category I CPT code for posterior vertebral column arthroplasty, effective Jan 1, 2028; until then the procedure is reported with Category III code 0202T. TOPS received FDA PMA in June 2023 with a superiority claim over TLIF for grade 1 degenerative spondylolisthesis with stenosis (two-year overall clinical success 77% vs 24%). Second source: https://orthotw.com/2026/10/ama-cpt-editorial-panel-votes-to-establish-a-category-i-cpt-code-for-posterior-vertebral-column-arthroplasty (quotes from CEO Ron Sacher and VP Reimbursement Jeff Withrow). 0202T current coding per Premia's physician coding guide, https://premiaspine.com/wp-content/uploads/2024/07/TOPS-System-Physician-Coding-Quick-Reference.pdf. No prior Morning Brief coverage of Premia/TOPS (grep of all drafts). Source
  • J Neurosurg Spine, Washington State Spine COAP registry: intrawound antibiotics not associated with fewer surgical site infections across 24,015 instrumented spine cases — Laynes et al., J Neurosurg Spine, online Oct 2, 2026 (doi 10.3171/2026.4.SPINE251431). Retrospective cohort of prospectively collected Spine COAP data, adult instrumented cervical or lumbar surgery July 2011 to January 2024: 256 of 24,015 (1.1%) developed SSI. Intrawound antibiotic use RR 0.90 (95% CI 0.70-1.16) univariate and not an independent predictor after adjustment. Independent predictors: open approach RR 4.94 (2.26-10.79), lumbar procedures RR 2.33 (1.45-3.75); higher serum albumin protective RR 0.35 (0.24-0.51). Observational; agent and dose not specified in the abstract. Related prior coverage: OTA 2026 local tobramycin RCT on the 2026-09-30 episode. Source
  • CORR target trial emulation of 4,564 Japanese periprosthetic hip fractures: no clear 30- or 90-day mortality difference between surgery within two days and surgery on days three to ten — Yoshiyama T, Fukasawa T, Anno T, Masuda S, Matsuda S, Kawakami K (Kyoto University). Does Early Surgery Reduce Mortality Compared With Delayed Surgery Among Patients With Periprosthetic Hip Fracture? A Target Trial Emulation. Clin Orthop Relat Res, online ahead of print Oct 1, 2026. doi 10.1097/CORR.0000000000004146; PMID 42821763; Level III therapeutic. Source verification (2026-10-04): every spoken figure checked against the published abstract retrieved via NCBI E-utilities (https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=42821763&rettype=abstract&retmode=text); title, authors, journal and online date confirmed via Crossref (https://api.crossref.org/works/10.1097/CORR.0000000000004146). Full text not accessed; narration limited to what the abstract states. Japanese hospital administrative database 2014-2024; 4,626 potentially eligible, 62 excluded, 4,564 eligible; mean age 84, 80% female. Clone-censor-weight emulation: early = surgery within 2 days of admission, delayed = days 3-10; clones censored for nonadherence, inverse probability weighting for artificial censoring and loss to follow-up; 95% CIs from 500 bootstraps. 30-day mortality 1.72% early vs 0.83% delayed (RD 0.89%, 95% CI -0.32% to 1.72%; RR 2.06, 0.64-3.73), 'no clear evidence of a difference, although the estimates were higher under the early strategy'. 90-day 2.35% vs 2.31% (RD 0.04%, -1.08% to 1.24%; RR 1.01, 0.59-1.68), near the null. Conventional analysis by observed timing gave lower 30-day estimates (1.10% vs 0.48%), attributed to immortal time and selection on eventual surgery. Authors' conclusion: findings do not support assuming the 48-hour native hip fracture standard applies to periprosthetic fractures solely to reduce short-term mortality; surgeons may consider time for medical stabilization and operative planning, but findings do not justify avoidable delay because other outcomes were not evaluated; future studies should incorporate fracture severity, operative complexity and surgical resources and evaluate complications, reoperation and functional recovery. No conflicts declared. Source

Contribute to the Brief

Faculty can send the show a note — a reaction to a paper, a correction, a read on a rule change — either written, which we shape for broadcast and read in the show's voice, or as a voice note under three minutes, which airs in your own voice. Send one from Studio.

Not on doc social yet? Contribute a lecture or join the network — doc social is a clinical education platform for clinicians, and this show is one part of it.

Narration is synthesized. Reporting and editorial judgement are ours, and every story above links to its source.